Adil Maarouf
Overview
Explore the profile of Adil Maarouf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demortiere S, Stolowy N, Perriguey M, Boutiere C, Rico A, Hilezian F, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Mar;
12(3):e200386.
PMID: 40085804
Background And Objectives: A simple, quick, and reproducible procedure for distinguishing multiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and neuromyelitis optica spectrum disorder (NMOSD) at inaugural optic neuritis...
2.
Rigollet C, Freeman S, Perriguey M, Stellmann J, Graille-Avy L, Lafontaine J, et al.
Neurotherapeutics
. 2025 Feb;
:e00554.
PMID: 39979176
The potential benefits of extended-interval dosing (EID) of rituximab (RTX) or ocrelizumab (OCR) in mitigating the reduction of immunoglobulin levels and decreasing the risk of infection in persons with relapsing-remitting...
3.
Guttieres L, Vannelli L, Demortiere S, Perriguey M, Elziere M, Durozard P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(2):e200379.
PMID: 39908480
Objectives: To evaluate the sensitivity of fluorescein angiography (FA) in detecting disease activity in Susac syndrome. Methods: We conducted a blinded analysis of all FA, brain MRI, and audiogram examinations...
4.
Grapperon A, El Mendili M, Maarouf A, Ranjeva J, Guye M, Verschueren A, et al.
PLoS One
. 2025 Jan;
20(1):e0316916.
PMID: 39841674
Objective: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by significant heterogeneity among patients. 23Na MRI maps abnormal sodium homeostasis that reflects metabolic alterations and energetic failure contributing to...
5.
Durozard P, Maarouf A, Zaaraoui W, Stellmann J, Boutiere C, Rico A, et al.
Invest Radiol
. 2024 Jun;
59(11):747-753.
PMID: 38889240
Objectives: Compelling evidence indicates a significant involvement of cortical lesions in the progressive phase of multiple sclerosis (MS), significantly contributing to late-stage disability. Despite the promise of ultra-high-field magnetic resonance...
6.
Maarouf A, Stellmann J, Rico A, Boutiere C, Demortiere S, Durozard P, et al.
J Neurol Neurosurg Psychiatry
. 2024 May;
95(10):974-978.
PMID: 38719433
Background: Progression independent of relapse activity (PIRA) has been described since the early stage of relapsing multiple sclerosis (RMS). However, little is known about the relation between PIRA and inflammatory...
7.
Graille-Avy L, Boutiere C, Rigollet C, Perriguey M, Rico A, Demortiere S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Apr;
11(3):e200231.
PMID: 38626360
Background And Objectives: Real-life studies noted that the risk of disease activity in multiple sclerosis (MS) after switching to rituximab (RTX) or ocrelizumab (OCR) may be unequal depending on prior...
8.
Cruz E, Fortanier E, Hilezian F, Maarouf A, Boutiere C, Demortiere S, et al.
Eur J Neurol
. 2024 Mar;
31(7):e16291.
PMID: 38532638
Background: The factors underlying the topography of nitrous oxide (NO)-induced neurological complications are unknown. Methods: We included all consecutive patients admitted to the university hospital of Marseille for NO-induced neurological...
9.
Demortiere S, Joubert B, Benaiteau M, Hilezian F, Boutiere C, Rico A, et al.
Neurology
. 2024 Mar;
102(8):e209284.
PMID: 38527243
No abstract available.
10.
Venet M, Lepine A, Maarouf A, Biotti D, Boutiere C, Casez O, et al.
Mult Scler
. 2024 Jan;
30(2):261-265.
PMID: 38166437
Recent studies in adults suggested that extended-interval dosing of rituximab/ocrelizumab (RTX/OCR) larger than 12 months was safe and could improve safety. This was an observational cohort study of very active...